Autori: Stanimirovic B
| Naslov | "Brilique/Ticagrelor/Safety Profile related to threshold of Toxicological concern/TTC/for impurities Ul127, Ul133, Ul134 and Ul 111 major objections of evaluation documentation for granting MA procedure by Medicines and Medical Devices Agency of Serbia-ALIMS (Proceedings Paper) |
| Autori | Stanimirovic Violeta V Nikolic Aleksandra T Nikolic Dejan V Stanimirovic Bojan Stanimirovic B |
| Info | PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY, (2013), vol. br. , str. 181-183 |
| Ispravka | Web of Science Citati: Web of Science |
     |
| Naslov | Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims (Proceedings Paper) |
| Autori | Stanimirovic Violeta V Nikolic Dejan V Nikolic Aleksandra T Stanimitovic B Stanimirovic B |
| Info | PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY, (2013), vol. br. , str. 177-180 |
| Ispravka | Web of Science Citati: Web of Science |
|
|
| Naslov | "Regulatory dilemma" of ongoing safety review of drug Gilenya (R) (fingolimod)-expierence from Medicines and Medical Devices Agency of Serbia-ALIMS (Proceedings Paper) |
| Autori | Stanimirovic Violeta V Nikolic Dejan V Nikolic Aleksandra T Stanimitovic B Stanimirovic B |
| Info | PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY, (2013), vol. br. , str. 169-171 |
| Ispravka | Web of Science Citati: Web of Science |
|
|
| Naslov | Clinical pharmacology (cp) vs. pharmaceutical medicine (pm) experience from serbia (Meeting Abstract) |
| Autori | Stanimirovic Violeta V Djakovic-Svajcer Kornelija Solarevic T Mikov Momir M  Cebedzic Rajko Stanimirovic B
|
| Info | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, (2009), vol. 105 br. , Suppl. Suppl. 1, str. 22-22 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
